ERVK-19
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
endogenous retrovirus group K member 19, envelope | HGNC:HGNC:39026 | 19q11 |
Gene Categories:
RNA DIRECTED DNA POLYMERASEGO terms in ERVK-19
Term Type | Evidence Type | GO Term ID | GO Des. |
---|
Gene expression in normal tissue: ERVK-19
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ERVK-19
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD125 | BIRB-796 | 1 |
iGMDRD681 | SB-743921 | 1 |
iGMDRD560 | MK-2206 | 1 |
iGMDRD594 | AZD-8055 | 1 |
iGMDRD20 | Embelin | 1 |
iGMDRD1036 | X17AAG | 1 |
iGMDRD79 | Gemcitabine | 1 |
iGMDRD382 | CEP-701 | 1 |
iGMDRD564 | GSK-650394 | 1 |
iGMDRD324 | CI-1040 | 1 |
iGMDRD450 | JNJ-26854165 | 1 |
iGMDRD176 | Decitabine | 1 |
iGMDRD352 | PD-0325901 | 1 |
iGMDRD18 | Cyclophosphamide | 1 |
iGMDRD396 | AS601245 | 1 |
iGMDRD381 | Rucaparib | 1 |
iGMDRD173 | Epothilone B | 1 |
iGMDRD402 | AKT Inhibitor VIII | 1 |
iGMDRD472 | PF-562271 | 1 |
iGMDRD552 | AZD-1775 | 1 |
iGMDRD42 | Vorinostat | 1 |
iGMDRD421 | AZD7762 | 1 |
iGMDRD946 | ML320 | 1 |
iGMDRD87 | Epigallocatechin-3-monogallate | 2 |
iGMDRD561 | ABT-263 | 1 |
iGMDRD779 | PRL-3 Inhibitor I | 1 |
iGMDRD546 | BMS-754807 | 1 |
iGMDRD489 | GSK-461364 | 1 |
iGMDRD462 | OSI-906 (Linsitinib) | 1 |
iGMDRD354 | Midostaurin | 1 |
iGMDRD112 | Methotrexate | 1 |
iGMDRD12 | Bicalutamide | 1 |
iGMDRD654 | SL 0101-1 | 1 |
iGMDRD659 | Avagacestat (BMS-708163) | 1 |
iGMDRD401 | Afatinib | 1 |
iGMDRD608 | Refametinib | 1 |
iGMDRD519 | GDC-0941 | 1 |
iGMDRD639 | YK 4-279 | 1 |
iGMDRD66 | Doxorubicin | 1 |
iGMDRD117 | Docetaxel | 1 |
iGMDRD700 | AUY922 | 1 |
iGMDRD291 | AC1NS4S0 | 1 |
iGMDRD131 | Erlotinib | 1 |
iGMDRD431 | NU-7441 | 1 |
iGMDRD602 | Foretinib | 1 |
iGMDRD399 | Selumetinib | 1 |
iGMDRD609 | BRD-K66453893 | 1 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in ERVK-19